Evaluating costs of a pharmacist-run thromboprophylaxis program

Formulary

Volumn 31, Issue 4, 1996, Pages 276-290

  Saltiel, Emmanuel ^a   Shane, Rita ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001146761     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Paiement G, Wessinger SJ, Waltman AC et al. Low-dose warfarin versus external pneumatic compression for prophylaxis against thromboembolism following total hip replacement. J Arthroplasty 1987;2:23-6.
2. Clagett GP, Salzman EW, Wheeler HB et al. Prevention of venous thromboembolism. Chest 1992;102:391S-407S.
3. Rivey MP, Wood RD, Allington DR et al. Evaluation of a Coumadin protocol in orthopedic surgery patients. Paper presented at 14th annual meeting of the American College of Clinical Pharmacists. Reno, NV: 1993. Abstract 28.
4. Rivey MP, Wood RD, Allington DR et al. Pharmacy-managed protocol for warfarin use in orthopedic surgery patients. Amer J Health-Syst Pharm 1995; 52:1310-6.
5. Bell DF, Harris WH, Kuter DJ et al. Elevated partial thromboplastin time as an indicator of hemorrhagic risk in postoperative patients on warfarin prophylaxis. J Arthroplasty 1988;3:181-4.
6. Gurwitz JH, Avom J. Ross-Degnan D et al. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med. 1992;116:901-4.
7. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994; 120:897-902.
8. Kawaguchi D, Ellis D. Effectiveness of 6 week, low dose warfarin in total hip replacement patients. Paper presented at Western States Conference for Pharmacy Residents, Fellows, and Preceptors. Asilomar, CA: 1993. Abstract 139.
9. Hirsh J. Dalen JE, Deykin D et al. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1992;102:312S-26S.
10. Shetty HGM, Backhouse G. Bentley DP et al. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K. Thromb Haemost 1992;67:13-5.
11. Hirsh J. Poller L. The international normalized ratio: A guide to understanding and correcting its problems. Arch Intern Med 1994;154:282-8.
12. Vanscoy GJ, Krause JR. Warfarin and the international normalized ratio: Reducing interlaboratory effects. DICP Ann Pharmacother 1991;25:1190-2.
13. Bussey HI, Force RW, Bianco TM et al. Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy. Arch Intern Med 1992; 152:278-82.
14. Vukovich T. Proidl S. Teufelsbauer H et al. Laboratory monitoring of thromboprophylaxis with low molecular weight and standard heparin. Thromb Res 1992;66:735-43.
15. Levine MN, Planes A, Hirsh J et al. The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparin low molecular weight heparin to prevent deep vein thrombosis after hip replacement. Thromb Haemost 1989; 62:940-4.
16. Mohr DN, Silverstein MD. Murtaugh PA, Harrison JM. Prophylactic agents for venous thrombosis in elective hip surgery: Meta-analysis of studies using venographic assessment. Arch Intern Med 1993;153:2221-8.
17. O'Brien BJ, Anderson DR, Goeree R. Cost-effectiveness of enoxaparin versus warfarin against deep-vein thrombosis after total hip replacement. Can Med Assoc J 1994;150:1083-90.
18. Menzin J. Colditz GA, Regan MM, et al. Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery. Arch Intern Med 1995;155:757-64.
19. Imeperiale TF, Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994;271:1780-5.
20. Hull R. Raskob G. Pineo G et al. A comparison of subcutaneous low-molecular weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993;329:1370-6.
21. Paiement GD, Wessinger SJ, Harris WH. Cost-effectiveness of prophylaxis in total hip replacement. Am J Surg 1991;161:519-24.
22. Klepser ME, Herbert J. Evaluation of a systematic warfarin-dosing protocol. P & T 1994;19:866,871-2,875-6.